Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma

Quality Improvement at an Academic Cancer Center: Venous Thromboembolism Prophylaxis in Patients With Multiple Myeloma

Patients with multiple myeloma are at elevated risk of venous thromboembolism (VTE), the second leading cause of death in patients with cancer, but physician adherence to VTE prevention guidelines is low. Several organizations partnered in designing and implementing a 2-year quality improvement (QI)...

Full description

Bibliographic Details
Main Authors:	Rachid Baz MD, Roy Furman MD, PhD, Katherine Simondsen PharmD, BCOP, Christine Stone PhD, MBA
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-06-01
Series:	Cancer Control
Online Access:	https://doi.org/10.1177/1073274820930204

Similar Items

Postpartum prophylaxis of venous thromboembolism with anticoagulation: A case report
by: Yahya A. Mohzari, Pharm.D, et al.
Published: (2021-04-01)

Venous Thromboembolism Prophylaxis in Underweight Hospitalized Patients
by: Douglas Buckheit PharmD, et al.
Published: (2021-06-01)

Patient Satisfaction With Venous Thromboembolism Treatment
by: David Webb PharmD, et al.
Published: (2019-08-01)

Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status
by: Alpesh Amin MD, MBA, et al.
Published: (2019-01-01)

Venous Thromboembolism Prophylaxis with Rivaroxaban in Elective Foot and Ankle Surgery
by: Martin J. Wiewiorski MD, et al.
Published: (2016-08-01)

Multimodal Venous Thromboembolism Thrombophilia Screening Examinations for Prophylaxis with Preoperative Total Hip and Knee Arthroplasties
by: Yasushi Oshima, MD, PhD, et al.
Published: (2015-12-01)

Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis
by: Jenna K. Lovely, PharmD, RPh, BCPS, et al.
Published: (2020-04-01)

Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism (FondaPPP)
by: Carl-Erik Dempfle MD, et al.
Published: (2021-05-01)

Zika and Chikungunya Virus and Risk for Venous Thromboembolism
by: Eduardo Ramacciotti MD, PhD, et al.
Published: (2019-01-01)

Validation of the Khorana Venous Thromboembolism Risk Score in Japanese Cancer Patients
by: Fumie Akasaka-Kihara, MD, et al.
Published: (2021-09-01)

Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis
by: Olivia S. Costa PharmD, et al.
Published: (2020-10-01)

Reduced Activity of Protein S in Plasma: A Risk Factor for Venous Thromboembolism in the Japanese Population
by: Xiuri Jin PhD, et al.
Published: (2021-07-01)

Venous Thromboembolism after the Repair of Abdominal Incisional Hernia with a Pedicled Anterolateral Thigh Flap
by: Tomohiro Iwata, MD, et al.
Published: (2020-04-01)

Predictors of Recurrent Venous Thromboembolism after Pulmonary Embolism in Korea
by: Yang-Ki Kim, M.D., Ph.D.
Published: (2019-10-01)

Venous Thromboembolism in a Young Man With Fused Renal Ectopia
by: Daiki Tomidokoro, MD, et al.
Published: (2020-12-01)

Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study
by: Hakeam A. Hakeam MS Pharm, BCPS, et al.
Published: (2020-06-01)

Reducing Hospitalizations and Emergency Department Visits in Patients With Venous Thromboembolism Using a Multicomponent Care Transition Intervention
by: Alok Kapoor MD, MSc, et al.
Published: (2020-01-01)

Prophylaxis of venous thromboembolism – The guidelines are there
by: Paulo Pinho
Published: (2017-09-01)

Principal Component Analysis on Recurrent Venous Thromboembolism
by: Tiago D. Martins PhD, et al.
Published: (2019-12-01)

Protein C deficiency resulting from two mutations in PROC presenting with recurrent venous thromboembolism
by: Weijia Xie, MD, et al.
Published: (2017-12-01)

The Incidence and Characteristics of Venous Thromboembolism in Neurocritical Care Patients: A Prospective Observational Study
by: Ping Zhang MD, et al.
Published: (2020-02-01)

PERIOPERATIVE PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ROUTINE ONCOSURGERY
by: V. E. Khoronenko, et al.
Published: (2016-12-01)

Venous Thromboembolism Prophylaxis: Inadequate and Overprophylaxis When Comparing Perceived Versus Calculated Risk
by: Rahul Chaudhary, MD, et al.
Published: (2017-12-01)

Diet as prophylaxis and treatment for venous thromboembolism?
by: Cundiff David K, et al.
Published: (2010-08-01)

Prophylaxis of Venous Thromboembolism in Psychiatric Inpatients
by: Sónia Pereira, et al.
Published: (2021-10-01)

Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study
by: Soo-Mee Bang MD, PhD, et al.
Published: (2021-01-01)

Changes in Biomarkers of Coagulation, Fibrinolytic, and Endothelial Functions for Evaluating the Predisposition to Venous Thromboembolism in Patients With Hereditary Thrombophilia
by: Lei Li PhD, et al.
Published: (2020-09-01)

Aspirin used for venous thromboembolism prophylaxis in total hip arthroplasty decreases heterotopic ossification
by: Kenneth M. Vaz, MD, et al.
Published: (2020-06-01)

Prediction and Diagnosis of Venous Thromboembolism Using Artificial Intelligence Approaches: A Systematic Review and Meta-Analysis
by: Qi Wang MS, et al.
Published: (2021-06-01)

Extracellular vesicles in ovarian cancer - A role in venous thromboembolism?
by: Mark P. Ward, PhD
Published: (2021-05-01)

Prevention of Venous Thromboembolism After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Development of a Physiotherapy Program
by: Xin-Bao Li MD, et al.
Published: (2019-11-01)

Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis
by: Stefan Hohaus, et al.
Published: (2020-05-01)

Hospital Length of Stay Is Associated With Increased Likelihood for Venous Thromboembolism After Total Joint Arthroplasty
by: Brett Salomon, MD, et al.
Published: (2021-04-01)

Solid Tumor Complicated With Venous Thromboembolism: A 10-Year Retrospective Cross-Sectional Study
by: Miao Peng MD, et al.
Published: (2021-02-01)

Prophylaxis of Venous Thromboembolism in Patients with Infectious Disease
by: Hun-Gyu Hwang, et al.
Published: (2020-07-01)

Venous thromboembolism prophylaxis: Solutions are in our hands
by: Al-Hameed Fahad
Published: (2011-01-01)

Venous thromboembolism prophylaxis in hospitalized medical patients
by: Matija Kozak, et al.
Published: (2018-03-01)

Clinical Impact of Coagulation and Fibrinolysis Markers for Predicting Postoperative Venous Thromboembolism in Total Joint Arthroplasty Patients
by: Yuying Cheng MD, et al.
Published: (2019-10-01)

Combination therapy with riociquat and inhaled treprostinil in inoperable and progressive chronic thromboembolic pulmonary hypertension
by: John W. Swisher, PhD, MD, et al.
Published: (2017-01-01)

Venous Thromboembolism Prophylaxis: Need for Continuous Assessment Due to Changes in Risk During the Same Hospitalization
by: Rahul Chaudhary, MD, et al.
Published: (2020-04-01)